A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation

Jianyun Liu, Richard M. Gallo, Carol Duffy, Randy R. Brutkiewicz

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

CD1d-restricted T (natural killer T [NKT]) cells are important for controlling a herpes simplex virus (HSV) infection. One of the mechanisms of immune evasion by HSV is to downregulate CD1d-mediated activation of NKT cells. VP22 is an HSV-1-encoded protein responsible for reorganizing the host cell's cytoskeletal network and viral spreading. We have previously shown that modification of the cytoskeleton can alter CD1d-mediated antigen presentation. In this study, we found that an HSV-1 lacking VP22 (ΔUL49) was impaired in its ability to inhibit CD1d-mediated antigen presentation compared with the wild-type (WT) virus; this was reversed by a repair virus (UL49R) in CD1d-expressing cells. We further demonstrated that CD1d recycling was inhibited by infection with WT and UL49R, but not the ΔUL49 virus. Ectopic expression of VP22 in CD1d-expressing cells complemented the VP22-deficient virus in inhibiting antigen presentation. Moreover, inhibiting viral protein synthesis rescued VP22-dependent inhibition of CD1d antigen presentation. In conclusion, our findings suggest that VP22 is required (but not sufficient) for the inhibition of CD1d-mediated antigen presentation by an HSV-1 infection.

Original languageEnglish (US)
Pages (from-to)409-416
Number of pages8
JournalViral Immunology
Volume29
Issue number7
DOIs
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Virology

Fingerprint Dive into the research topics of 'A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation'. Together they form a unique fingerprint.

  • Cite this